A detailed history of Harvest Fund Management Co., LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 672 shares of UTHR stock, worth $243,425. This represents 0.01% of its overall portfolio holdings.

Number of Shares
672
Previous 1,180 43.05%
Holding current value
$243,425
Previous $375,000 36.0%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$311.04 - $363.55 $158,008 - $184,683
-508 Reduced 43.05%
672 $240,000
Q2 2024

Aug 08, 2024

BUY
$228.26 - $319.04 $269,346 - $376,467
1,180 New
1,180 $375,000
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $29,306 - $34,356
-159 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $28,597 - $34,165
159 New
159 $29,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.